http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006061502-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4adb6419d4a776103627b3f8a415c19c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32
filingDate 2005-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52fe003b30213be8f1556850b2a976aa
publicationDate 2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006061502-A1
titleOfInvention Tablets for the sustained release of indapamide and preparation method thereof
abstract The invention relates to a tablet for the sustained release of indapamide, which can be used for the treatment of essential arterial hypertension. The inventive tablet contains no polyvidone, but instead a mixture of at least two hydrophilic cellulosic polymers with different viscosities, such as hydroxypropylmethylcelluloses, which can be used to control the sustained release. Optionally, the tablet can be coated.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023001880-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112370433-A
priorityDate 2004-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0577504-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0519820-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6607754-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5000962-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128685069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226525889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12598931

Total number of triples: 35.